The Current Dynamics in Capital Markets

Back Bay Life Science Report

Content provided by Back Bay Life Science Advisors, Jonathan P. Gertler, and Peter Bak. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Back Bay Life Science Advisors, Jonathan P. Gertler, and Peter Bak or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

2M ago 22:25

MP3•Episode home

Welcome to another episode with the DNB//Back Bay Partnership for Healthcare.

In this episode Jonathan Gertler, Back Bay CEO and Managing Partner, is once again joined by James Cirenza, Head of Fixed Income and Equities at DNB, Kristoffer Braaten, Director of US Equity Capital Markets at DNB, and Vasilios Kofitsas, Managing Director of Investment Banking at Back Bay Life Science Advisors, to talk about current market dynamics and the 2024 IPO outlook in the US and in Europe.

Topics in this podcast include:

Trends, cycles and the current state of capital markets in Europe and the US
IPO performance for Q1 2024 vs. previous years
Top characteristics of companies well-suited to go public and be successful
IPO market dynamics in Europe vs. the US
Expectations and advice for companies contemplating going public

As always we welcome listener questions and/or topics you’d like to learn more about.

You can listen to previous episodes here or submit your inquiries to info@bblsa.com.

Learn more about the DNB//Back Bay Partnership and read our disclaimers at https://www.bblsa.com/dnb-back-bay-partnership.

28 episodes

#Fitness #Medicine #Bay Life Science Advisors #Jonathan P. Gertler #Biopharma #Investmentbanking #LifeSciences #Medtech